obesity drug news today glp-1 october 23 2025 Receptor Agonist Market Valued at USD 62.86 Billion in 2025, Set to Grow at 17.5% CAGR Through 2034 Dozens of new obesity drugs

8 A case-control study that compared 25,956 patients who had vitamin B 12 deficiency with 184,199 control patients found a significantly increased risk of vitamin B 12 deficiency in patients who had taken proton pump inhibitors (odds ratio = 1.65) or histamine H 2 blockers (odds ratio = 1.25) for at least two years

Rich in antioxidants, vitamins, collagen, and botanical extracts

To be explicit: clinicians should not present ipamorelin and CJC-1295 to patients as proven therapies for any of these goals

However, when sold for "research" or "anti-aging" purposes outside of its approved indication, it falls into a regulatory gray area

Results from this study confirm that MRAB biofilm matrix integration is significantly dependent on the biopolymers present, and this finding aligns with previous studies, which reported that eDNA, polysaccharides and proteins play an essential role in A